The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...

As bird flu continues to ramp up, many are wondering what tools—namely, vaccines—we have to fight it if such intervention ...

Wockhardt's new oral antibiotic Miqnaf approved for community-acquired bacterial pneumonia, offering effective treatment for resistant infections.

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.

Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.

PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established ...

The House Task Force on Artificial Intelligence (AI) released a comprehensive 253-page report providing a roadmap for Congress as it develops ...

US woman has gene-edited pig-kidney transplant, and scientists hope experimental surgery could save thousands of lives ...

Anavex Life Sciences remains one of the few non-amyloid Alzheimer's drug developers. Find out why I rate AVXL stock as a Hold ...